ANTHRASIL®

ANTHRASIL is an Anthrax Immune Globulin Intravenous (Human) indicated for the treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs. The effectiveness of ANTHRASIL is based solely on efficacy studies conducted in animal models of inhalational anthrax.

Notify me on updates of this product 

Availability: Commercially Available

Rebecca Fish
Vice President of Marketing & Product Strategy
fishr@ebsi.com
+1 240 631 3200
400 Professional Drive, Suite 400
Gaithersburg, MD 20879
USA
www.emergentbiosolutions.com/our-products
Manufacturer
Emergent BioSolutions, Inc.
Product Name
ANTHRASIL®
Detection Category
Biological
Detection Method
Medical Countermeasure
Application
Personal Protective Equipment;
Equipment Type
PPE
Product Synopsis
ANTHRASIL is an Anthrax Immune Globulin Intravenous (Human) indicated for the treatment of inhalational anthrax in adult and pediatric patients in combination with appropriate antibacterial drugs. The effectiveness of ANTHRASIL is based solely on efficacy studies conducted in animal models of inhalational anthrax.
Availability
Commercially Available
Technology Readiness Level (TRL)
9
Market Entry Date
2015
User Feedback Sources
Indifferent/No user feedback
Weight
<1 lb.
Power Requirements
None
Transportability
Pocket Size
Live Agent Tested
Yes; B. anthracis (anthrax)
Operating Time
Immediate post-exposure use
Standards Met
FDA
Training Required
<1 hour training
Training Available
Yes
Manuals Available
Yes
Please enter contact info.
Email Address: 
Company: 
Name: 
Title: